About Contact Us Careers

Zoster Treatment Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3620
Published Date: Sep 19, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Zoster Treatment Landscape

Novartis AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Valeant Pharmaceuticals North America, LLC
Merck & Co., Inc.
Abbott Laboratories
Teva Pharmaceutical Ltd
Camber Pharmaceuticals, Inc.
Gilead Sciences Inc.
Mylan NV
GlaxoSmithKline plc
Maruho Co. Ltd.

Browse Key Market Insights with Data Illustration:

Zoster Treatment Market Size & Share | Growth Trends 2036

In the News

July 2021- GlaxoSmithKline announced that the U.S. Food and Drugs Administration approved Shingrix for the prevention of herpes zoster in adults aged 18 years or older, who are at increased risk of the condition

Author Credits: Radhika Pawar

Report ID: 3620
Published Date: Sep 19, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving market growth are high prevalence of zoster globally and rising introduction of vaccines and medications for self-treatment.

The market is anticipated to attain a CAGR of ~14% over the forecast period, i.e., 2022 â€“ 2030.

High cost of zoster treatment is estimated to hamper the market growth.

Asia Pacific will provide more business opportunities for market growth owing to the growing occurrence of herpes zoster, and rising initiatives by governmental and non-governmental organizations associated with vaccination drives.

The major players in the market are Valeant Pharmaceuticals North America, LLC, Merck & Co., Inc., Abbott Laboratories, Teva Pharmaceutical Ltd, and others.

Inquiry Before Buying Request Free Sample